We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for dexrazoxane (Maxx Pharma Pty Ltd)
Active ingredients
dexrazoxane
Sponsor
Date of review outcome
Lapse date
Type
Orphan Drug
Dosage form(s)
powder for solution for injection/infusion
Indication
For use in the prevention of cardiotoxicity caused by anthracycline use
Therapeutic area
Cardiovascular